Otsuka Pharmaceutical Companies (U.S.)

At Otsuka, putting our patients and communities first is at the heart of all we do. With this mission in mind, we proudly support Clubhouse International , a nonprofit focused on ending social and economic isolation for those living with mental illness, in a multi-year commitment.  With more than 360 Clubhouses in 33 countries, this commitment supports the Clubhouse International Intensive Employee Support program, helping Clubhouse International expand its employment support so more Clubhouse members gain and maintain employment. To date, we've proudly helped strengthen employment outcomes at 97 Clubhouses and are committed to ongoing support through our funding and additional support beyond dollars.  At Otsuka, we hold a deep respect for the value of every mind. We will not rest until mental illnesses and brain diseases are approached with the same priority and urgency as our physical health and recognized as chronic diseases that warrant early, equitable, and accessible intervention for patients everywhere.  For more on our Social Impact work: https://lnkd.in/g7RbkydN

Driven by our purpose to defy limitation and our mission to create new products for better health worldwide, we believe in the value of every mind and will not rest until mental illnesses and brain diseases are approached with the same priority and urgency as our physical health and recognized as chronic diseases that warrant early, equitable, and accessible intervention for patients and caregivers everywhere.    This National Wellness Month, we continue to uphold our commitment to putting the health and safety of patients first and finding unconventional solutions for the unmet medical needs of underserved communities.     Discover our commitment to health for every mind: https://bit.ly/4c2fZpq

BREAKING: We are pleased to announce today that Otsuka Pharmaceutical Co., Ltd. and Jnana Therapeutics have entered into a merger agreement, in an effort to bring forth novel autoimmune solutions to patients.   Read more: https://bit.ly/3ypWA3P

“Agitation is one of the most complex and stressful aspects of caring for people living with Alzheimer's dementia,” said John Kraus, M.D., Ph.D., executive vice president and chief medical officer, Otsuka. Today, we are pleased to present, in collaboration with Lundbeck, the results from the new post hoc pooled analyses of Phase 3 trials evaluating the safety and efficacy for the treatment in patients with agitation associated with dementia due to Alzheimer’s disease. We are committed to persevere until mental health and brain diseases are approached with the same priority and urgency as physical health. Read more here: https://bit.ly/3YqnCCI #DefyLimitation

Meet Ty.   Ty is a sandwich generation caregiver to her mother, Gertrude.   Half (50%) of the sandwich generation caregivers that are caring for a loved one with Alzheimer’s disease or dementia report that they feel unprepared for the role.   As Ty raises her children, she navigates the intricacies of the caregiving journey that many are all too familiar with. Ty’s strength and resilience pushed her to find joy in difficult circumstances, and we are emotional hearing her powerful story.  Watch the latest installment of Still Here: Caregiver Conversations out now - https://bit.ly/4ditD9r   Ty is a paid collaborator of Otsuka America Pharmaceutical, Inc.

We're excited to be part of the upcoming National Sales Network (Headquarters) Conference and Career Fair in Houston, TX on August 7-9!   Come stop by Booth #307 to meet with our on-the-ground Otsuka team and hear about exciting career opportunities, including the chance to have on-site interviews.   We look forward to seeing you there! #NSN2024

Earlier this summer, we were humbled to be part of the first annual Stop Stigma Together (SST) summit to end the stigma against mental illness and substance use disorder. As part of our participation, we had the opportunity to share the findings from ‘The Projected Cost and Economic Impact of Mental Health Inequities in the United States report,’ authored by national expert Daniel Dawes, Dean of the Meharry School of Global Health with fellow attendees. Through our commitment to health for every mind, we will continue to emphasize that the mental health crisis in the United States should be treated as an emergency, encompassing a cross-sector approach. To read the full report: https://bit.ly/4dybF30 Otsuka is proud to be a lead, founding sponsor of 'The Projected Cost and Economic Impact of Mental Health Inequities in the United States Report.’

This National Intern Day, we would like to thank all our InTOW interns for such a dynamic summer with us. Our 50+ interns continuously live by our purpose: defy limitation, so that others can too.   Their motivated work, innovative thinking, and resourceful creativity are unparalleled, as they demonstrate what it truly means to be an Otsuka-person.  As we come to the close of our program in the next couple of weeks, we wish all of them good luck on their journey ahead!   #NationalInternDay #DefyLimitation

Did you know that 43% of caregivers sacrifice their mental well-being due to their responsibilities as an Alzheimer’s disease or dementia family caregiver? At Otsuka, we’re working to lead an industry-wide shift in the ways caregivers are valued and supported. We are dedicated to caring for caregivers—standing with them, the way they stand with their loved ones—and offering the tools they need for the health of others and themselves. Our newly released fridge magnet provides caregivers with a moment to stop and process their feelings, and the many layers of emotions that come with providing this support for a loved one. If you're a family caregiver, how are you feeling today? For more information on our commitment to caregivers: https://lnkd.in/g4dtSda4

We are grateful to continue our work with Missy Franklin to raise awareness of autosomal dominant polycystic kidney disease (ADPKD), a rare genetic condition that causes cysts to form on the kidneys, eventually leading to a decline in kidney function and requiring a need for dialysis or a transplant.   For more than 20 years, Otsuka has brought new research and expertise to the #nephrology space. Our long-term perseverance has led to significant breakthroughs, giving patients renewed hope and clinicians more options.   Watch Missy speak of her family's journey with ADPKD on CBS Mornings. Missy Franklin is a paid collaborator of Otsuka America Pharmaceutical, Inc.